Budget Amount *help |
¥19,240,000 (Direct Cost: ¥14,800,000、Indirect Cost: ¥4,440,000)
Fiscal Year 2012: ¥3,250,000 (Direct Cost: ¥2,500,000、Indirect Cost: ¥750,000)
Fiscal Year 2011: ¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2010: ¥11,440,000 (Direct Cost: ¥8,800,000、Indirect Cost: ¥2,640,000)
|
Research Abstract |
Cardiac cell therapy has been proposed as one of the new strategies against heart failure; however, the mechanisms of the beneficial effects are largely unknown. We found that soluble junctional adhesion molecule-A (JAM-A), which is secreted from transplanted cardiac progenitor cells, prevent cardiac remodeling and reduce fibrosis area after myocardial infarction. In addition, by using a genetic fate-mapping model, we found that both leukemia inhibitory factor and transplantation of cardiac progenitor cells stimulate endogenous cardiomyocyte renewal after myocardial infarction.
|